Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11166950 | Treatment of cancer with TOR kinase inhibitors | Shuichan Xu, Heather Raymon, Rama Krishna Narla, Rajesh Chopra | 2021-11-09 |
| 11096940 | Treatment of hepatocellular carcinoma characterized by hepatitis B virus infection | Ellen Filvaroff, Shaoyi Li | 2021-08-24 |
| 10391092 | Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy | Heather Raymon, Toshiya Tsuji, Rama Krishna Narla | 2019-08-27 |
| 10183019 | Treatment of cancer with dihydropyrazino-pyrazines | Heather Raymon | 2019-01-22 |
| 9980963 | Treatment of cancer with dihydropyrazino-pyrazines | Heather Raymon, Shuichan Xu, Antonia Lopez-Girona, Toshiya Tsuji | 2018-05-29 |
| 9937169 | Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy | Heather Raymon, Toshiya Tsuji, Rama Krishna Narla | 2018-04-10 |
| 9937170 | Treatment of cancer with TOR kinase inhibitors | Shuichan Xu, Antonia Lopez-Girona, Heather Raymon, Rama Krishna Narla, Rajesh Chopra | 2018-04-10 |
| 9630966 | Treatment of cancer with dihydropyrazino-pyrazines | Heather Raymon | 2017-04-25 |
| 9505764 | Treatment of cancer with dihydropyrazino-pyrazines | Heather Raymon, Shuichan Xu, Antonia Lopez-Girona, Toshiya Tsuji | 2016-11-29 |
| 9493466 | Treatment of cancer with TOR kinase inhibitors | Shuichan Xu, Antonia Lopez-Girona, Heather Raymon, Rama Krishna Narla, Rajesh Chopra | 2016-11-15 |
| 9474757 | Methods for treating cancer using TOR kinase inhibitor combination therapy | Rajesh Chopra | 2016-10-25 |
| 9375443 | Method for treating advanced non-small cell lung cancer (NSCLC) by administering a combination of a TOR kinase inhibitor and azacitidine or erlotinib | Shuichan Xu, Tam Minh Tran | 2016-06-28 |
| 9358232 | Methods for treating cancer using TOR kinase inhibitor combination therapy | Rajesh Chopra | 2016-06-07 |
| 9119854 | Methods for treating cancer using combination therapy | Rajesh Chopra | 2015-09-01 |